1. Mansour SE, Browning DJ, Wong K, Flynn HW Jr, Bhavsar AR. The Evolving Treatment of Diabetic Retinopathy. Clin Ophthalmol. 2020;14:653-678. [
DOI:10.2147/OPTH.S236637] [
PMID] [
PMCID]
2. Endris T, Worede A, Asmelash D. Prevalence of Diabetes Mellitus, Prediabetes and Its Associated Factors in Dessie Town, Northeast Ethiopia: A Community-Based Study. Diabetes Metab Syndr Obes. 2019;12:2799-2809. [
DOI:10.2147/DMSO.S225854] [
PMID] [
PMCID]
3. Asmat U, Abad K, Ismail K. Diabetes mellitus and oxidative stress-A concise review. Saudi Pharm J. 2016;24(5):547-553. [
DOI:10.1016/j.jsps.2015.03.013] [
PMID] [
PMCID]
4. Semeraro F, Morescalchi F, Cancarini A, Russo A, Rezzola S, Costagliola C. Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications. Diabetes Metab. 2019;45(6):517-527. [
DOI:10.1016/j.diabet.2019.04.002] [
PMID]
5. Shaito A, Thuan DTB, Phu HT, Nguyen THD, Hasan H, Halabi S, Abdelhady S, Nasrallah GK, Eid AH, Pintus G. Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety. Front Pharmacol. 2020;11:422. [
DOI:10.3389/fphar.2020.00422] [
PMID] [
PMCID]
6. Hidayat R, Wulandari P. Effects of Andrographis paniculata (Burm. F.) extract on diabetic nephropathy in rats. Rep Biochem Mol Bio. 2021;10(3):445-54. [
DOI:10.52547/rbmb.10.3.445] [
PMID] [
PMCID]
7. Wediasari F, Nugroho GA, Fadhilah Z, Elya B, Setiawan H, Mozef T. Hypoglicemic effect of a combined Andrographis paniculata and Caesalpinia sappan extract in streptozocin-induced diabetic rats. Adv Pharmacol Pharm Sci. 2020;8856129. [
DOI:10.1155/2020/8856129] [
PMID] [
PMCID]
8. Rocházková D, Bousová I, Wilhelmová N. Antioxidant and prooxidant properties of flavonoids. Fitoterapia. 2011;82(4):513-23. [
DOI:10.1016/j.fitote.2011.01.018] [
PMID]
9. Gheibi S, Kashfi K, Ghasemi A. A practical guide for induction of type-2 diabetes in rat: incorporating a high-fat diet and streptozotocin. Biomed Pharmacother. 2017;95:605-13. [
DOI:10.1016/j.biopha.2017.08.098] [
PMID]
10. Vucetic M, Jensen PK, Jansen EC. Diameter variations of retinal blood vessels during and after treatment with hyperbaric oxygen. Br J Opthalmol. 2004;88:771-5. [
DOI:10.1136/bjo.2003.018788] [
PMID] [
PMCID]
11. Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione-S-transferase activities in lung and liver. Biochem Biophys Acta. 1979;582(1): 67-78. [
DOI:10.1016/0304-4165(79)90289-7] [
PMID]
12. Misra HP, Fridovich I. The oxidation of phenylhydrazine: superoxide and mechanism. Biochemistry. 1976;15:681-7. [
DOI:10.1021/bi00648a036] [
PMID]
13. Aebi H. Catalase. In: Bergmeyer HU, ed. Methods in enzymatic analysis. 1st ed. New York. Academic Press, 1974:673-7. [
DOI:10.1016/B978-0-12-091302-2.50032-3]
14. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin-phenol reagent. J Biol Chem. 1951;193:265-75. [
DOI:10.1016/S0021-9258(19)52451-6] [
PMID]
15. Andrade-Cetto A, Rubalcaba Mares ML. Hypoglycemic effect of the Rhizophora mangle Cortex on STZ-NA induced diabetic rats. Pharmacol Online. 2012;3(3):1-5.
16. National Research Council (US) Institute for Laboratory Animal Research. Guide for the Care and Use of Laboratory Animals. Washington (DC): National Academies Press (US);1996.
17. Bek T. Diameter Changes of Retinal Vessels in Diabetic Retinopathy. Curr Diab Rep. 2017;17(10):82. [
DOI:10.1007/s11892-017-0909-9] [
PMID]
18. Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds M. Complications of Diabetes 2017. J Diabetes Res. 2018;2018:3086167. [
DOI:10.1155/2018/3086167] [
PMID] [
PMCID]
19. Klein R, Myers CE, Lee KE, Gangnon R, Klein BE. Changes in retinal vessel diameter and incidence and progression of diabetic retinopathy. Arch Ophthalmol. 2012;130(6):749-55. [
DOI:10.1001/archophthalmol.2011.2560] [
PMID] [
PMCID]
20. Gui F, You Z, Fu S, Wu H, Zhang Y. Endothelial Dysfunction in Diabetic Retinopathy. Front Endocrinol (Lausanne). 2020;11:591. [
DOI:10.3389/fendo.2020.00591] [
PMID] [
PMCID]
21. Kaštelan S, Orešković I, Bišćan F, Kaštelan H, Gverović Antunica A. Inflammatory and angiogenic biomarkers in diabetic retinopathy. Biochem Med (Zagreb). 2020;30(3):030502. [
DOI:10.11613/BM.2020.030502] [
PMID] [
PMCID]
22. Behl Y, Krothapalli P, Desta T, DiPiazza A, Roy S, Graves DT. Diabetes-enhanced tumor necrosis factor- production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Am J Pathol. 2008;172(5):1411-8. [
DOI:10.2353/ajpath.2008.071070] [
PMID] [
PMCID]
23. Zafar MI, Mills K, Ye X, Blakely B, Min J, Kong W, et al. Association between the expression of vascular endothelial growth factors and metabolic syndrome or its components: a systematic review and meta-analysis. Diabetology Metab Syndrome. 2018;10:62. [
DOI:10.1186/s13098-018-0363-0] [
PMID] [
PMCID]
24. Semadi IN. The role of VEGF and TNF-alpha on epithelialization of diabetic foot ulcers after hyperbaric oxygen therapy. Open Access Maced J Med Sci. 2019;7(19):3177-83. [
DOI:10.3889/oamjms.2019.297] [
PMID] [
PMCID]
25. Balbi ME, Tonn FS, Mendes AM, Borba HH, Wiens A, Fernandez-Llimos F, et al. Antioxidant effects of vitamins in type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetol Metab Syndr. 2018;10:18. [
DOI:10.1186/s13098-018-0318-5] [
PMID] [
PMCID]
26. Albert-Garay JS, Riesgo-Escovar JR, Salceda R. High glucose concentrations induce oxidative stress by inhibiting Nrf2 expression in rat Müller retinal cells in vitro. Sci Rep. 2022;12(1):1261. [
DOI:10.1038/s41598-022-05284-x] [
PMID] [
PMCID]